The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity

Detalles Bibliográficos
Autores principales: Kotwinski, Paul, Smith, Gillian, Sanders, Julie, Ma, Louise, Cooper, Jackie, Thomas, Michael, Mythen, Michael (Monty) G, Jones, Alison, Montgomery, Hugh E, Pennell, Dudley J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559572/
http://dx.doi.org/10.1186/1532-429X-15-S1-O94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559572/
http://dx.doi.org/10.1186/1532-429X-15-S1-O94

Ejemplares similares